申请人:MEMORY PHARMACEUTICALS CORP.
公开号:US20020151566A1
公开(公告)日:2002-10-17
PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I:
1
wherein R
1
, R
2
, R
3
and R
4
are as defined herein.
PDE4抑制剂是通过新型化合物实现的,例如N-取代苯胺和二苯胺类似物。本发明的化合物为公式I:1其中R1、R2、R3和R4如本文所定义。